-
Aug 12, 10 06:07AMThe study propose to measure the inflammation level in type 1 diabetes children with the cytokine analysis compared to non diabetic children of the same sibling and to healthy children.Location: Children Hospital, Endocrinology Unit Status: Not yet recruiting» Read more
-
Aug 12, 10 06:13AMThe primary purpose of this study is to determine if giving the combination therapy consisting of Thymoglobulin® (ATG) and Neulasta® (GCSF) to patients with established Type 1 Diabetes (T1D) is safe and secondarily, if the ATG and GCSF will preserve insulin production.Location: University of Florida Status: Recruiting» Read more
-
Aug 12, 10 06:49AMThe investigators hypothesize that our closed-loop glucose-control system can provide BG control in subjects with type 1 diabetes using the estimated BG signal from a CGM as the input signal to the controller.Location: Massachusetts General Hospital Status: Recruiting» Read more
-
Aug 12, 10 07:33AMThe purpose of this study is to evaluate the feasibility, efficacy and safety of transplantation therapy using bone marrow mononuclear cells and umbilical cord mesenchymal stem cells for patients with type 1 diabetes mellitusLocation: Armed Police General Hospital, P. R. China Status: Not yet recruiting» Read more
-
Aug 12, 10 10:20AMThis trial is conducted in Europe. The aim of this trial is to investigate the absorption and effect in the body of NN1218 in subjects with type 1 diabetes.Status: Completed» Read more
-
Aug 12, 10 11:03AMThe purpose of the study is to determine whether the function of the good cholesterol (HDL cholesterol) is altered among people with type 1 diabetes and a variation in the Haptoglobin gene and to evaluate whether vitamin E supplements may improve this function.Location: University of Pittsburgh Diabetes and Lipid Res... Status: Recruiting» Read more
-
Aug 12, 10 11:15AMThe purpose of this study is to determine the effects of sitagliptin on glucose variability both after meals and overnight in adult patients with type 1 diabetes.Location: Barbara Davis Center for Childhood Diabetes Status: Completed» Read more
-
Oct 13, 10 08:10AMThe purpose of this study is to determine whether umbilical cord Mesenchymal Stem Cells of treatment for initial type 1 diabetes is safe and effective.Location: Stem Cell Research Center of Medical School Hos... Status: Active, not recruiting» Read more
-
Jan 19, 11 07:00AMThe project aims at assessment of the effect of the FTO gene polymorphism and the type of treatment on the development of overweight/obesity and features of metabolic syndrome in children with type 1 diabetes. Gene polymorphism including some genetic variants may predispose to the development of cardiovascular diseases and their complications. The A allele of the FTO ge...Location: Department of Pediatrics, Endocrinology and Dia... Status: Recruiting» Read more
-
Feb 25, 11 08:00AMAlpha-1 Antitrypsin (AAT), trade name (Glassia ®), is being explored in this phase I/II trial as a potential disease modifying agent in Type 1 Diabetes Mellitus (T1DM) based on its anti-inflammatory properties. AAT is an acute stress reactant protein that increases during inflammation. In T1DM inflammation serves a major role in disease progression.Location: Institute for Endocrinology and Diabetes, Natio... Status: Not yet recruiting» Read more
Type 1 Diabetes
For patients, caregivers and medical professionals that are interested in learning more about Type 1 Diabetes (also known as Juvenile Diabetes, T1D, T1DM, or IDDM).
Clinical Trials
New Clinical Trials for Type 1 Diabetes. See all or search for more Clinical Trials.
Join to have conversations with knowledgeable people and get real-time updates
Question Guidelines
- Anything you write on Medpedia Answers is publicly viewable and searchable.
- Questions should be a request for information only — not a request for direct medical advice, a diagnosis, or a treatment plan.
Examples:
- Is a sore throat a symptom of swine flu?
- What are the benefits and drawbacks of a tonsillectomy?
-
Peter Hofland Ph.DEditor
Senior Editor, Sunvalley Communicatione
-
Jeffrey B Matthews PhDEditor
Dir. Communications, Immune Tolerance Network
-
Private Practitioner
-
Outreach Manager, Immune Tolerance Network
-
Compliance Analyst
-
You must be a member of this Community to do that.
Join this Community to:
- Ask a question
- Start or join a discussion
- Get real-time email updates
You must be a member of this Community to do that.
Join this Community to:
- Ask a Question
- Start or Join a Discussion
- Get real-time email updates
Join this Community to:
- Ask a question
- Start or join a discussion
- Get real-time email updates
Join this Community to:
- Ask a question
- Start or join a discussion
- Get real-time email updates